Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hysteroscopic Repeat Curettage vs Methotrexate in Low-risk Postmolar Gestational Trophoblastic Neoplasia
NCT03703271Phase 2Recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Mar 2019
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in gestational trophoblastic neoplasia (GTN) (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoint: Complete Response Rate at 2 years. Started Mar 2019; status: recruiting.
02
Conditions
gestational trophoblastic neoplasia (GTN)
Beyond the preview
Go deeper on NCT03703271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03703271.